Stock Analysis

Oxford Nanopore Technologies Full Year 2024 Earnings: EPS Beats Expectations

LSE:ONT
Source: Shutterstock
Advertisement

Oxford Nanopore Technologies (LON:ONT) Full Year 2024 Results

Key Financial Results

  • Revenue: UK£183.2m (up 8.0% from FY 2023).
  • Net loss: UK£146.2m (loss narrowed by 5.4% from FY 2023).
  • UK£0.16 loss per share (improved from UK£0.18 loss in FY 2023).
earnings-and-revenue-growth
LSE:ONT Earnings and Revenue Growth March 6th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Oxford Nanopore Technologies EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 11%.

Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Europe.

Performance of the market in the United Kingdom.

The company's shares are down 17% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for Oxford Nanopore Technologies that you should be aware of before investing here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About LSE:ONT

Oxford Nanopore Technologies

Engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Flawless balance sheet with limited growth.

Advertisement